Clinical trial designs--made to order.

At times, clinical trial design presents difficult problems for the consulting statistician. The nature of the disease under study or the inadequacies of standard methodology often suggest alternative strategies for the development of useful clinical trial designs. This paper examines two case of novel clinical trial designs that are "made-to-order" for the problem at hand. Both address disease-specific issues. The first case considers the use of adaptive allocation of treatments to patients in a trial in major depressive disorder. The second case reviews the design of a novel efficacy parameter in advanced pancreatic cancer.

[1]  A. Rush,et al.  Alprazolam vs amitriptyline in depressions with reduced REM latencies. , 1985, Archives of general psychiatry.

[2]  D. V. Von Hoff,et al.  A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  D. V. Von Hoff,et al.  Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  J. Krook,et al.  A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5‐fluorouracil, doxorubicin, and cisplatin , 1990, Cancer.

[5]  T. Fleming,et al.  A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin. , 1985, JAMA.

[6]  Robert H. Bartlett,et al.  Randomized play the winner clinical trials , 1986 .

[7]  E. Casper Pancreatic cancer: how can we progress? , 1993, European journal of cancer.

[8]  S. Arbuck Overview of chemotherapy for pancreatic cancer , 1990, International journal of pancreatology : official journal of the International Association of Pancreatology.

[9]  L. J. Wei,et al.  The Randomized Play-the-Winner Rule in Medical Trials , 1978 .

[10]  A. Rush,et al.  Reduced REM latency predicts response to tricyclic medication in depressed outpatients , 1989, Biological Psychiatry.